2016 IPM Annual Report: Hope, Progress and the Power of Prevention

In 2016, IPM’s monthly dapivirine ring became the first microbicide and first long-acting product to reduce women’s risk for HIV in two Phase III trials. IPM’s 2016 annual report looks back at this and other milestones that hold promise for adding new tools to women’s HIV prevention options. Available below in HTML or PDF.

2016 IPM Annual Report (HTML)

2016 IPM Annual Report (PDF)